Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer

Bai, YF; Zhang, ZZ; Cheng, LJ; Wang, RX; Chen, XL; Kong, YF; Feng, F; Ahmad, N; Li, L; Liu, XQ

Liu, XQ (reprint author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.

JOURNAL OF BIOLOGICAL CHEMISTRY, 2019; 294 (25): 9911

Abstract

Enzalutamide, approved by the United States Food and Drug Administration in 2018 for the management of metastatic castration-resistant prostate cancer......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索